{
  "abstract": "A woman in her 30s with a known case of polycythaemia vera [Janus Kinase 2 (JAK2) V617F-positive] presented to the clinic with progressive changes in skin and nail pigmentation. She had been receiving hydroxyurea 500 mg two times per day for the past 5 years following her diagnosis. Approximately 1 year after initiating therapy, she began noticing brownish discolouration of her face along with dark longitudinal streaks in her fingernails. On discontinuing or reducing the dose, she had a history of reduced pigmentations. Similarly, increasing the dose was associated with increased pigmentation. She denied taking any other medications, and her medical history was otherwise unremarkable.",
  "authors": [
    {
      "affiliations": [
        "Physical Medicine and Rehabilitation (PM&R), National Cancer Institute (NCI--AIIMS), Jhajjar Campus, All India Institute of Medical Sciences, New Delhi, Delhi, India"
      ],
      "name": "Raktim Swarnakar"
    }
  ],
  "title": "Hydroxyurea-induced multisite cutaneous and nail pigmentation in a patient with polycythaemia vera",
  "uid": "63656e5d-c7f3-5e83-90e3-90a2175b0112"
}